CTRI/2023/10/058621尚未招募2 期
Accelerated Hypofractionated Palliative Radiotherapy Vs Standard Hypofractionated Palliative Radiotherapy With Concurrent Chemotherapy In Locally Advanced Head And Neck Carcinoma: A Randomised Controlled Study - nil
AIIMS, New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Treatment naive, Histo-pathologically proven Squamous Cell Carcinoma of head and neck region excluding nasopharyngeal, para-nasal sinus and salivary gland primary
- •-Defined as incurable or palliative intent by Head and Neck multidisciplinary team (MDT)
- •-Adequate organ functions and bone marrow reserve
- •-Eastern Co-operative Oncology Group Performance Score (ECOG PS)- (0-3)
- •-Age: 18- 70 years
- •-Negative viral serology markers (HIV, HBsAg, HCV)
- •-Giving written Informed consent
排除标准
- •-Nasopharyngeal, para-nasal sinus or salivary gland primary
- •-Recurrent disease
- •-Metastatic disease
- •-Patients who have previously received oncologic treatment with surgery, radiotherapy or chemotherapy
- •-Pregnant patients
- •-Synchronous malignancy or any other malignancy with in last 5 years
- •-Known uncontrolled medical comorbidities which could impact QOL
研究者
相似试验
进行中(未招募)
不适用
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in adenocarcinoma of the esophagus or esophogastric junction trial - a phase II clinical trial protocol.EUCTR2014-002362-74-SESkåne University Hospital, Department of Oncology
已完成
不适用
Quality of Life After Conformal Radiotherapy in Late Stage Oral Cavity Cancer:A Prospective clinical TrialCTRI/2018/03/012441Jawaharlal Institue of Postgraduate Medical Education and research25
已完成
2 期
Intensity-modulated, hypofractionated radiotherapy with scanning beam protons for locally advanced carcinoma of the prostate and localized carcinoma of the prostate with risk factors - a phase II studyC61Malignant neoplasm of prostateDRKS00011912Westdeutsches Protonentherapiezentrum Essen (WPE)133
已完成
1 期
Hypofractionated radiotherapy for low and intermediate-risk prostate cancer using robot-tracking stereotactic radiotherapy -phase I/II clinical trialprostate cancerJPRN-UMIN000014328Osaka University Graduate School of Medicine75
招募中
3 期
Standard moderately hypofractionated radiotherapy vs. ultra-hypofractionated focal lesion ablative microboost in prostate cancer, Hypo-FLAME 3.010038597prostate cancerNL-OMON56327Antoni van Leeuwenhoek Ziekenhuis352
